Latest blog articles
-
Unlike other sectors, improvements in Genetic technology raise issues of morality. The new human gene editing technology CRISPR/CAS9 has raised many such concerns. Can the current patent system deal with these concerns or should morality be dealt with by the inventors themselves?
-
Thoughts on the outcome of the negotiation session performed by students where they combined an academic EU perspective on private law rules for the EU internal market, with a political perspective of a Member State.
-
Course on European Contract Law - how has it been in the past 5 years?
-
Moot court and DCFR - what did we take with us from this experience?